U.S. Markets open in 16 hrs, 53 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,226.94 | 203.52 | 2.03% |
| NASDAQ | 2,154.06 | 41.62 | 1.97% |
| S&P 500 | 1,093.07 | 23.77 | 2.22% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| EPS (TTM): | -1.10 | Current P/E Ratio: | -0.79091 |
|---|---|---|---|
| Last Quarter's Earnings: | -0.13 | Current Quarter Estimate: | -0.165 |
| Last Fiscal Year Earnings: | -1.98 | Next Fiscal Year Estimate: | -0.745 |
| Analyst Consensus: | Buy | Dividend Rate: | 0.00 |
| Last Dividend: | 0.00 |
First Call Consensus Recommendation Buy
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 03/29/2010 * | 18:00 | Q4 2009 Cyclacel Pharmaceuticals, Inc. Earnings Release |  |
| 12/01/2009 | 18:00 | Cyclacel Pharmaceuticals, Inc. at New York Society of Security Analysts Biotech & Specialty Pharmaceuticals Industry Conference | |
| 11/17/2009 | 15:55 | Cyclacel Pharmaceuticals, Inc. at Lazard Capital Healthcare Conference | |
| 11/10/2009 | 19:20 | Cyclacel Pharmaceuticals, Inc. at Merriman Curhan Ford Investor Summit | |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/03/2009 | Q3 2009 Cyclacel Pharmaceuticals, Inc. Earnings Conference Call | — | — |
| 11/03/2009 | Q3 2009 Cyclacel Pharmaceuticals, Inc. Earnings Release | — | — |
| 10/29/2009 | Cyclacel Pharmaceuticals, Inc. at The 8th Annual BIO Investor Forum |  |
— |
| 09/10/2009 | Cyclacel Pharmaceuticals, Inc. at Rodman & Renshaw Annual Global Investment Conference | — | — |
| 08/06/2009 | Q2 2009 Cyclacel Pharmaceuticals, Inc. Earnings Conference Call | — | — |
| 08/06/2009 | Q2 2009 Cyclacel Pharmaceuticals, Inc. Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts